Please login to the form below
influenza
This page shows the latest influenza news and features for those working in and with pharma, biotech and healthcare.
Pfizer signs $425m flu vaccine deal with Germany’s BioNTech
Pfizer has teamed up with German biotech BioNTech to develop a new generation of influenza vaccines that can be made quicker and more cheaply than current products. ... New flu vaccines are needed to provide improved protection against seasonal flu, and
Latest news
-
Your health is about more than just your health
emergency care use, lower use of mammography, lower receipt of influenza vaccine, poorer ability to demonstrate taking medications appropriately, poorer ability to interpret labels and health messages, and, among seniors, poorer
-
Roche’s Tamiflu successor hits the mark in complicated flu
Roche has reported a second pivotal data on a novel influenza drug – baloxavir marboxil – that it says is the first drug with a new mechanism of action for the viral infection
-
Incisive Health and 90TEN take home Integrated Communications awards
The partners built advocacy throughout the UK influenza network, and helped bring about major changes in UK influenza guidance from the JCVI and NHS England on the use of Fluad as
-
Daily Brief, CAR-T update, new leukaemia treatments, universal flu hope and more
Promisingly, it also achieved a reduction in influenza infection rates and severity and duration of symptoms observed, with a 60% reduction in confirmed flu infections and an 83% reduction in the ... FLU-v is a broad spectrum vaccine covereing A, B and
-
Sanofi backs vaccines unit with €350m Canadian facility
Last year’s performance was driven by Sanofi’s paediatric and influenza vaccines, and the pharma company has also been investing in the latter category.
More from news
Approximately 20 fully matching, plus 197 partially matching documents found.
Latest Intelligence
-
Deal Watch February 2016
coli and influenza, and in toxicology applications. While Abbott already has a significant diagnostics presence with global sales in 2015 in this segment of $4.6bn, it forecasts that the acquisition
-
Another lost decade for research?
diseases that cause significant morbidity and mortality, such as influenza and malaria, but remain difficult to vaccinate against.
-
Pharma deals in June 2015
85. BioCryst Pharmaceuticals/ CSL. RAPIVAB (peramivir injection) for the treatment of influenza (marketed).
-
Wearables: the tangible product of the patient revolution
The opportunity is massive - in the public health arena, there exists the possibility that outbreaks of diseases such as Ebola or influenza could be seen and stopped before they become critical.
-
Deal Watch table for October 2014
318. Novartis/CSL. Asset purchase. Influenza vaccines. 275. Five Prime/GSK. Expansion of collaboration.
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest appointments
-
Germany's Ventaleon names biotech entrepeneur CEO
patients suffering from serious infections such as influenza to get better, faster.
-
Dr Michael Watson appointed as president of Valera
Dr Watson brings twenty years of vaccines expertise to the role and has broad experience in the development and licensing of vaccines for conditions such as smallpox, encephalitis and influenza.
-
NDA Group appoints Bill Griffiths as general manager, UK
systems teams as well as a specialist influenza vaccines unit.
-
Takeda appoints head of vaccines development
Boslego will be responsible for accelerating global vaccine development activities with a focus on lead development programmes for dengue, norovirus and seasonal influenza.
-
MHRA chairman steps down
He was previously chair of the MHRA's Commission of Human Medicines and the Department of Health's Scientific Pandemic Influenza Committee.
More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest from PMHub
-
To track disease, follow the money
The way that influenza spreads can be tracked by tools such as Flusurvey,(1) which produces rapidly-updated heatmaps of illness across the country.
-
Influenza
Agency: BASTARD. LONDON. Product: Self Promotion. Client: Self Promotion. Therapy area: Self Promotion. View the PMHub profile for: BASTARD. LONDON.
-
To track disease, follow the money
The way that influenza spreads can be tracked by tools such as Flusurvey,(1) which produces rapidly-updated heatmaps of illness across the country.
More from PMHub
Approximately 2 fully matching, plus 1 partially matching documents found.
Featured jobs
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Systematic Review Lead- London
-
Negotiable
-
Associate Scientific Director
-
Salary TBC
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Healthcare PR Senior Account Manager
-
Salary TBC
-
Account Manager
-
Negotiable
- Account Director or Senior Account Director
-
Salary TBC
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
Subscribe to our email news alerts
- New Awards scheme for medical and scientific professionals
- Random42 Exhibiting at BioCap Conference 2018
- Bedrock scoops top prizes at Digital Awards
- After Lucentis setback, Novartis trumpets data on follow-up drug
- Labour party divided on Brexit ‘People’s Vote’
- CHMP backs Spark’s Luxturna, but rejects Sarepta again
PMHub
PRMA Consulting Ltd
PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...
Latest intelligence
- The gene therapy revolution
- Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
Quick links
Infographics
